Angiopathy in ankylosing spondylitis


  • Ie.D. Iegudina SI “Dnipropetrovsk Medical Academy”, Dnipro, Ukraine
  • O.V. Syniachenko Donetsk National Medical University, Lyman, Ukraine
  • O.E. Chernyshova Donetsk National Medical University, Lyman, Ukraine
  • T.R. Polesova Donetsk National Medical University, Lyman, Ukraine
  • M.V. Ermolaeva Donetsk National Medical University, Lyman, Ukraine



ankylosing spondylitis, vessels, diagnosis, pathogenesis


Background. Ankylosing spondylitis is a chro­nic progressive systemic autoimmune rheumatic disease of the spine, peripheral joints, sacroiliac joints, enthesis, ligamentous apparatus and internal organs, and related to risk factors of severe vascular disease. The purpose of our work was to study clinical and instrumental course of angiopathy, find pathogenetic connection with immune parameters in ankylosing spondylitis. Materials and methods. The study included 79 patients aged 15 to 66 years (mean 38 years old), among whom there were 95 % of men and 5 % of women. The duration of the disease from its first manifestation was 11 years, I degree of activity occurred in 32 % of cases, II — in 39 % and III — in 29 %, and the ratio of slow-progressive to the rapidly progressive course of the pathological process was 4 : 1. Peripheral monooligoartritis was ascertained in 47 % of patients, polyarthritis — in 53%. Patients underwent echocardiography, vascular doppler ultrasound, biomicroscopy of vessels of the conjunctiva. Results. Angiopathy occurs in 85 % of patients with ankylosing spondylitis, the development of which is linear related to the degree of activity of pathological process and inversely to the seropositivity by rheumatoid factor. Cutaneous vasculitis depends on the age of patients; uveitis, scleritis, Raynaud’s syndrome, damage of the central and peripheral nervous system depend on the peculiarities of articular syndrome clinical course. Integrated clinical and instrumental vascular indices significantly correlated with immune parameters (levels of rheumatoid factor, C-reactive protein, circulating immune complexes, values of immunoglobulinemia) and vascular damage occurs with increased pulmonary artery pressure and vascular resistance in genesis of which C-reactive protein is involved that could be a prognostic value.


Download data is not yet available.


Boonen A, Sieper J, van der Heijde D. The burden of non-radiographic axial spondyloarthritis. Semin Arthritis Rheum. 2015 Apr;44(5):556-62. doi: 10.1016/j.semarthrit.2014.10.009.

Chee MM, Sturrock RD. Ankylosing spondylitis. Scott Med J 2007;52(4):32-5.

Genre F, López-Mejías R, Miranda-Filloy JA, Ubilla B, Carnero-López B, Blanco R, Pina T, González-Juanatey C, Llorca J, González-Gay MA. Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis. Biomed Res Int 2014;20(14):860651. doi: 10.1155/2014/860651.

Grewal GS, Leipsic J, Klinkhoff AV. Abdominal aortitis in HLA-B27+ spondyloarthritis: case report with 5-year follow-up and literature review. Semin Arthritis Rheum 2014;44(3):305-8. doi: 10.1016/j.semarthrit.2014.05.012.

Jamshidi AR, Shahlaee A, Farhadi E, Fallahi S, Nicknam MH, Bidad K, Barghamadi M, Mahmoudi M. Clinical characteristics and medical management of Iranian patients with ankylosing spondylitis. Mod Rheumatol 2014;24(3):499-504. doi: 10.3109/14397595.2013.844302.

Klimek E, Sulicka J, Gryglewska B, Skalska A, Kwaśny-Krochin B, Korkosz M, Grodzicki TK. Alterations in skin microvascular function in patients with rheumatoid arthritis and ankylosing spondylitis. Clin Hemorheol Microcirc 2016;4(11):163-8.

Rohekar S, Chan J, Tse SM, Haroon N, Chandran V, Bessette L, Mosher D, Flanagan C, Keen KJ, Adams K, Mallinson M, Thorne C, Rahman P, Gladman DD, Inman RD. 2014 Update of the Canadian Rheumatology Association/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. Part I: principles of the management of spondyloarthritis in Canada. J Rheumatol 2015;42(4):654-64. doi: 10.3899/jrheum.141000.

Sieper J. New treatment targets for axial spondyloarthritis. Rheumatology 2016;55(2):38-42.

Stone JR, Bruneval P, Angelini A, Bartoloni G, Basso C, Batoroeva L, Buja LM, Butany J, d'Amati G, Fallon JT, Gittenberger-de Groot AC, Gouveia RH, Halushka MK, Kelly KL. Consensus statement on surgical pathology of the aorta from the society for cardiovascular pathology and the association for european cardiovascular pathology: I. inflammatory diseases. Cardiovasc. Pathol 2015;24 (5):267-78. doi: 10.1016/j.carpath.2015.05.001.

Surdacki A, Sulicka J, Korkosz M, Mikolajczyk T, Telesinska-Jasiówka D, Klimek E, Kierzkowska I, Guzik T, Grodzicki TK. Blood monocyte heterogeneity and markers of endothelial activation in ankylosing spondylitis. J Rheumatol 2014;41(3):481-9. doi: 10.3899/jrheum.130803.

Tyrrell JS, Redshaw CH. Physical activity in ankylosing spondylitis: evaluation and analysis of an health tool. J Innov Health Inform 2016;23(2):169-79. doi: 10.14236/jhi.v23i2.169.

Usenbo A, Kramer V, Young T, Musekiwa A. Prevalence of arthritis in Africa: A systematic review and meta-analysis. PLoS One 2015;10(8):0133858. doi: 10.1371/journal.pone.0133858.

Xu L, Heath J, Burke A. Ascending aortitis: a clinicopathological study of 21 cases in a series of 300 aortic repairs. Pathology 2014;46(4):296-305. doi: 10.1097/PAT.0000000000000096.

Zhang X, Liu R, Wang J, Zhang Y, Liu Y, Yu Z, Yu S. Risk of premature cerebrovascular disease in patients with ankylosing spondylitis. Acta Reumatol Port 2016 Oct-Dec;41(4):322-327. PMID: 27182728.



How to Cite

Iegudina, I., Syniachenko, O., Chernyshova, O., Polesova, T., & Ermolaeva, M. (2021). Angiopathy in ankylosing spondylitis. PAIN, JOINTS, SPINE, 7(1), 27–31.



Practical Medicine

Most read articles by the same author(s)

1 2 3 > >>